The EV Truck War Is Officially On
Motley Fool Money
00:00
Navigating Investment Strategies in Biotech: A Focus on Eli Lilly
This chapter contrasts the investment potential of established biotech firms like Eli Lilly with smaller, riskier companies. It highlights Lilly's robust drug pipeline and discusses the implications of high valuation metrics while advocating for caution in investment decisions, especially near peak stock prices.
Play episode from 15:00
Transcript
